BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10643895)

  • 1. Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein.
    Dodart JC; Mathis C; Bales KR; Paul SM; Ungerer A
    Neurosci Lett; 1999 Dec; 277(1):49-52. PubMed ID: 10643895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
    Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein--initial observations.
    Diez M; Koistinaho J; Kahn K; Games D; Hökfelt T
    Neuroscience; 2000; 100(2):259-86. PubMed ID: 11008166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
    Bigl M; Apelt J; Eschrich K; Schliebs R
    J Neural Transm (Vienna); 2003 Jan; 110(1):77-94. PubMed ID: 12541014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ji Y; Quartermain D; Jensen CH; Duff K; Nixon RA; Gruen RJ; Wisniewski T
    J Neuropathol Exp Neurol; 2004 May; 63(5):418-28. PubMed ID: 15198121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein.
    Niwa K; Kazama K; Younkin SG; Carlson GA; Iadecola C
    Neurobiol Dis; 2002 Feb; 9(1):61-8. PubMed ID: 11848685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology.
    Bigl M; Apelt J; Luschekina EA; Lange-Dohna C; Rossner S; Schliebs R
    Neurosci Lett; 2000 Oct; 292(2):107-10. PubMed ID: 10998560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
    Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.
    Boncristiano S; Calhoun ME; Howard V; Bondolfi L; Kaeser SA; Wiederhold KH; Staufenbiel M; Jucker M
    Neurobiol Aging; 2005 May; 26(5):607-13. PubMed ID: 15708435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.
    Johnson-Wood K; Lee M; Motter R; Hu K; Gordon G; Barbour R; Khan K; Gordon M; Tan H; Games D; Lieberburg I; Schenk D; Seubert P; McConlogue L
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1550-5. PubMed ID: 9037091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
    Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
    Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.
    Reilly JF; Games D; Rydel RE; Freedman S; Schenk D; Young WG; Morrison JH; Bloom FE
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4837-42. PubMed ID: 12697936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of electroacupuncture on the behavior and the expression of amyloid beta-protein, amyloid precursor protein and ChAT in APP 695 V 717 I transgenic mice].
    Xue WG; Zhang Z; Bai LM; Xu H; Wu HX
    Zhen Ci Yan Jiu; 2009 Jun; 34(3):152-8. PubMed ID: 19761106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease.
    Murphy GM; Zhao F; Yang L; Cordell B
    Am J Pathol; 2000 Sep; 157(3):895-904. PubMed ID: 10980129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
    Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F
    Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.